Just launched · October 2026—Rankings get sharper with every edition.Spotted an error?Tell us →
Sign in / Register

Ubie

Active#31 in Japan

Estimated valuation · AI symptom checker · Japan

AI symptom checker and medical-information platform that helps patients find conditions and clinics, plus hospital software that automates medical interviews.

Founded2017
HQTokyo
RaisedJPY 10.7bn+ (2022)
Last roundSeries C2 · Oct 2022
Country of originJapanListed in the Japan ranking
Where would you invest?JapanJurisdiction as cited by the ranking

Estimated valuation

AI · Japan ranking
≈ USD 220MUSD 150–330M · Hundreds of M$
Anchor
Last known equity round: Series C2 · USD 43M · Oct 2022
AI adjustment
None

An indicative editorial estimate produced by AI, imperfect by nature: neither a financial valuation nor investment advice. Only the market sets a company’s value. Method

Uback rankings

How the AI ranks →
RankingTierRankEditionNext update
Japan · all sectorsTop 50#31Edition 0 · October 202610 Jan 2027
Rank historyOct 2026 · #31First edition: no movements yet.

Funding history

JPY 10.7bn+ (2022) raised in total
DateRoundAmountTypeInvestors
Oct 2022Series C2USD 43MEquity—

Rounds as cited by Uback’s rankings. Equity, debt and grants are shown separately; only equity rounds count towards the valuation anchor.

Independent analyses

By industry professionals & analysts

Industry professionals and financial analysts can publish their own analysis of Ubie as a PDF. It must answer at least one of these four questions, and stick to them:

AI valuation: $220MUndervalued or overvalued?
Versus competitorsHow does it compare?
Who should acquire itStrategic buyers, and why
Who should it acquireAcquisition targets, and why
Publish an analysisName, role and LinkedIn shown · public sources only

Analyses are the opinion of their authors, not of Uback. They are checked before publication.

Comparable companies in Japan

Full Japan ranking →

Last updated: Oct 2026Report an error

Uback is a content publisher and an aggregator of non-binding expressions of interest. It provides no investment advice, receives no mandate and takes part in no transaction. Rankings, ranges and brackets are editorial estimates produced by AI, purely indicative.